Search results
Showing results for
The world’s number-one treatment for malaria is on the brink of failure because of a new strain of drug-resistant parasites — unless health policymakers take action. Professor Sir Nicholas White says that the mosquito-borne parasite responsible for severe malaria is now showing resistance to the prime treatment, Artemisinin Combination Therapy (ACT), across South-East Asia. If this resistance jumps to Africa, he warns, the tragedy will be on a massive scale.
Rachel Hounsell
Rachel Hounsell - Senior Researcher and Teaching Fellow
Proochista Ariana
- MSc IHTM Executive Team
- MSc IHTM Lecturers
- MSc IHTM advisory committee
- MSc MGH Lecturers
- Principal Investigators
- Research Scientists
Proochista Ariana - Associate Professor
Wirichada Pan-ngum
Wirichada Pan-ngum - Associate Professor
Kevin Marsh
Kevin Marsh - Professor of Tropical Medicine
Marco Liverani
Marco Liverani - Honorary Visiting Research Fellow in Tropical Medicine
Philippe Guérin
Philippe Guérin - Professor of Epidemiology and Global Health
Christiane Dolecek
MD PHD FRCP Christiane Dolecek - Professor of Global Health
Louise Thwaites
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Professor of Experimental Critical Care
Phaik Yeong Cheah
Phaik Yeong Cheah - Professor of Global Health
Evelyne Kestelyn
Evelyne Kestelyn - Head of the Clinical Trials Unit
Bridget Wills
Bridget Wills - Professor of Tropical Medicine